Andrew E. Libby

725 total citations
19 papers, 454 citations indexed

About

Andrew E. Libby is a scholar working on Physiology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Andrew E. Libby has authored 19 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 6 papers in Epidemiology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Andrew E. Libby's work include Lipid metabolism and biosynthesis (6 papers), Diet, Metabolism, and Disease (5 papers) and Adipose Tissue and Metabolism (5 papers). Andrew E. Libby is often cited by papers focused on Lipid metabolism and biosynthesis (6 papers), Diet, Metabolism, and Disease (5 papers) and Adipose Tissue and Metabolism (5 papers). Andrew E. Libby collaborates with scholars based in United States, Hong Kong and Italy. Andrew E. Libby's co-authors include David J. Orlicky, James L. McManaman, Elise S. Bales, Jenifer Monks, Moshe Levi, Suman Ranjit, Enrico Gratton, Bryce A. Jones, Francisco G. La Rosa and Rachel H. McMahan and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Andrew E. Libby

19 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew E. Libby United States 11 158 139 139 107 71 19 454
Carrie A. Millward United States 9 203 1.3× 125 0.9× 124 0.9× 48 0.4× 66 0.9× 9 457
Michele K. Wu United States 10 265 1.7× 89 0.6× 158 1.1× 66 0.6× 100 1.4× 11 460
Sylvia Jacob Germany 16 311 2.0× 251 1.8× 155 1.1× 80 0.7× 131 1.8× 36 657
Barış Erçal United States 6 246 1.6× 212 1.5× 255 1.8× 48 0.4× 46 0.6× 9 528
Madlen Matz‐Soja Germany 15 300 1.9× 203 1.5× 99 0.7× 30 0.3× 94 1.3× 42 592
Usue Ariz Spain 11 318 2.0× 294 2.1× 61 0.4× 63 0.6× 67 0.9× 14 652
Elisa Balboa Chile 14 283 1.8× 304 2.2× 285 2.1× 46 0.4× 88 1.2× 20 748
Masayasu Inoue Japan 12 173 1.1× 58 0.4× 138 1.0× 121 1.1× 104 1.5× 14 509
Yanqing Chi China 13 259 1.6× 109 0.8× 79 0.6× 23 0.2× 49 0.7× 23 577

Countries citing papers authored by Andrew E. Libby

Since Specialization
Citations

This map shows the geographic impact of Andrew E. Libby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew E. Libby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew E. Libby more than expected).

Fields of papers citing papers by Andrew E. Libby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew E. Libby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew E. Libby. The network helps show where Andrew E. Libby may publish in the future.

Co-authorship network of co-authors of Andrew E. Libby

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew E. Libby. A scholar is included among the top collaborators of Andrew E. Libby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew E. Libby. Andrew E. Libby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Finlay-Schultz, Jessica, Heather M. Brechbuhl, Andrew E. Libby, et al.. (2025). Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Research. 27(1). 32–32. 2 indexed citations
2.
Roberson, Paul A., et al.. (2024). Lack of Sestrins Is Associated with Increased Glycolytic Flux. Physiology. 39(S1). 1 indexed citations
3.
Paul, Saikat, Andrew E. Libby, Jordan Patterson, et al.. (2023). HERV1-env Induces Unfolded Protein Response Activation in Autoimmune Liver Disease: A Potential Mechanism for Regulatory T Cell Dysfunction. The Journal of Immunology. 210(6). 732–744. 5 indexed citations
4.
Mao, Liufeng, Lijie Peng, Xiaomei Ren, et al.. (2022). Discovery of JND003 as a New Selective Estrogen-Related Receptor α Agonist Alleviating Nonalcoholic Fatty Liver Disease and Insulin Resistance. PubMed. 2(3). 282–296. 7 indexed citations
5.
Kurtz, Ryan, Andrew E. Libby, Bryce A. Jones, et al.. (2022). Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo Mice. International Journal of Molecular Sciences. 23(10). 5675–5675. 10 indexed citations
6.
Gavin, Kathleen M., Timothy M. Sullivan, Matthew R. Jackman, et al.. (2022). Hematopoietic Stem Cell-Derived Adipocytes Modulate Adipose Tissue Cellularity, Leptin Production and Insulin Responsiveness in Female Mice. Frontiers in Endocrinology. 13. 844877–844877. 3 indexed citations
7.
Monks, Jenifer, et al.. (2022). Perilipin-2 promotes lipid droplet-plasma membrane interactions that facilitate apocrine lipid secretion in secretory epithelial cells of the mouse mammary gland. Frontiers in Cell and Developmental Biology. 10. 958566–958566. 10 indexed citations
8.
Kahn, Darcy, Simona Zarini, Karin Zemski Berry, et al.. (2022). Exploring Visceral and Subcutaneous Adipose Tissue Secretomes in Human Obesity: Implications for Metabolic Disease. Endocrinology. 163(11). 47 indexed citations
9.
Takahashi, Shogo, Yuhuan Luo, Suman Ranjit, et al.. (2020). Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet–fed mice. Journal of Biological Chemistry. 295(14). 4733–4747. 50 indexed citations
10.
Libby, Andrew E., et al.. (2020). Nuclear receptors in the kidney during health and disease. Molecular Aspects of Medicine. 78. 100935–100935. 37 indexed citations
11.
Ranjit, Suman, Luca Lanzanò, Andrew E. Libby, Enrico Gratton, & Moshe Levi. (2020). Advances in fluorescence microscopy techniques to study kidney function. Nature Reviews Nephrology. 17(2). 128–144. 43 indexed citations
12.
Bruce, Kimberley D., Evgenia Dobrinskikh, Hong Wang, et al.. (2020). Neuronal Lipoprotein Lipase Deficiency Alters Neuronal Function and Hepatic Metabolism. Metabolites. 10(10). 385–385. 8 indexed citations
13.
Monks, Jenifer, David J. Orlicky, Adrianne L. Stefanski, et al.. (2018). Maternal obesity during lactation may protect offspring from high fat diet-induced metabolic dysfunction. Nutrition and Diabetes. 8(1). 18–18. 34 indexed citations
14.
Wang, Hong, et al.. (2018). Striated muscle gene therapy for the treatment of lipoprotein lipase deficiency. PLoS ONE. 13(1). e0190963–e0190963. 2 indexed citations
15.
Libby, Andrew E., Elise S. Bales, Jenifer Monks, David J. Orlicky, & James L. McManaman. (2018). Perilipin-2 deletion promotes carbohydrate-mediated browning of white adipose tissue at ambient temperature. Journal of Lipid Research. 59(8). 1482–1500. 31 indexed citations
16.
Orlicky, David J., Andrew E. Libby, Elise S. Bales, et al.. (2018). Perilipin‐2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra‐hepatocyte actions. The Journal of Physiology. 597(6). 1565–1584. 66 indexed citations
17.
Libby, Andrew E., Elise S. Bales, David J. Orlicky, & James L. McManaman. (2016). Perilipin-2 Deletion Impairs Hepatic Lipid Accumulation by Interfering with Sterol Regulatory Element-binding Protein (SREBP) Activation and Altering the Hepatic Lipidome. Journal of Biological Chemistry. 291(46). 24231–24246. 82 indexed citations
18.
Libby, Andrew E., et al.. (2015). Lipoprotein lipase is an important modulator of lipid uptake and storage in hypothalamic neurons. Biochemical and Biophysical Research Communications. 465(2). 287–292. 14 indexed citations
19.
Wang, Hong & Andrew E. Libby. (2014). An update on gene therapy for the treatment of lipoprotein lipase deficiency. 47–47. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carrie A. Millward Breakdown of academic impact, for papers by Michele K. Wu Breakdown of academic impact, for papers by Sylvia Jacob Breakdown of academic impact, for papers by Barış Erçal Breakdown of academic impact, for papers by Madlen Matz‐Soja Breakdown of academic impact, for papers by Usue Ariz Breakdown of academic impact, for papers by Elisa Balboa Breakdown of academic impact, for papers by Masayasu Inoue Breakdown of academic impact, for papers by Yanqing Chi
Rankless by CCL
2026